Form 4: Adaptive Biotechnologies Corp: President Julie Rubinstein Reports Stock Transactions

President Julie Rubinstein of Adaptive Biotechnologies Corp reports acquisition and disposition of common stock to cover tax obligations related to vesting RSUs.

Summary

• On March 4, 2024, Julie Rubinstein, President of Adaptive Biotechnologies Corp, acquired 175,000 shares of common stock at $0.
• On March 5, 2024, she disposed of 25,580 shares at $3.43 and 13,490 shares at $3.56.
• These sales were to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• Following these transactions, Rubinstein beneficially owns 472,754 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company insider to cover tax obligations. It doesn't inherently convey positive or negative sentiment about the company's performance.

Management Comments

• The sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities. These filings are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but it's primarily related to tax obligations.

Key Dates